Ocugen
OCGN | NASDAQ
$0.77
-$0.06 (-6.98%)
At close: Nov 16, 2026, 4:00 PM ET
$0.77
$0.00 (+0.48%)
After-hours:
Nov 16, 2026, 7:54 PM ET
-6.98%
(1D)No price chart data available for 1D timeframe.
Rating
43
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #445/1021 (Top 44%)
Key Statistics
Market Data
Market Cap $262.28M
1D Range
0.74 0.82
52W Range
0.70 2.48
Valuation (TTM)
PE -3.85
PB -14.83
EV/EBITDA -3.83
Valuation (NTM)
Forward PE 431.57
Forward PEG 0.33
Price Target $5.00
Cash Flow
FCF Yield -24.4%
SBC Adj. FCF Yield -27.9%
SBC Impact -14.4%
Margins
Gross Margin 88.5%
Operating Margin -1444.5%
FCF Margin -1337.2%
Growth (CAGR)
Revenue 3Y | 5Y 1.1% |
21.4%
Dil EPS 3Y | 5Y -5.0% |
15.8%
FCF 3Y | 5Y -13.3% |
2.2%
Returns
ROA -60.5%
ROE 644.0%
ROIC -94.4%
Financial Health
Net Debt
$638K
Current Ratio 0.77
Interest Coverage -6.76
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. Th...
Sector Healthcare
Industry Biotechnology
Employees 116
IPO Date Dec 3, 2014
Website www.ocugen.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.06
Beat 0.00%
YoY:
+14.29% REV
$1.95M
Beat +48.07%
YoY:
+11.36%Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$5.00
Upside
+549.35%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove OCGN